Telesis Bio Inc
NASDAQ:TBIO
Income Statement
Earnings Waterfall
Telesis Bio Inc
Income Statement
Telesis Bio Inc
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
4
|
2
|
|
| Revenue |
7
N/A
|
8
+14%
|
9
+16%
|
10
+13%
|
11
+12%
|
14
+30%
|
17
+20%
|
21
+23%
|
27
+30%
|
28
+2%
|
31
+11%
|
30
-4%
|
28
-8%
|
25
-10%
|
18
-29%
|
14
-23%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(3)
|
(3)
|
(5)
|
(6)
|
(7)
|
(9)
|
(10)
|
(11)
|
(12)
|
(12)
|
(12)
|
(11)
|
(11)
|
(10)
|
(9)
|
(7)
|
|
| Gross Profit |
4
N/A
|
4
+13%
|
4
-1%
|
4
+7%
|
4
-1%
|
6
+34%
|
8
+30%
|
10
+33%
|
16
+55%
|
16
+5%
|
19
+18%
|
19
-3%
|
17
-9%
|
15
-12%
|
8
-44%
|
6
-24%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(20)
|
(23)
|
(27)
|
(33)
|
(40)
|
(48)
|
(56)
|
(61)
|
(62)
|
(62)
|
(58)
|
(56)
|
(52)
|
(59)
|
(44)
|
(37)
|
|
| Selling, General & Administrative |
(11)
|
(13)
|
(17)
|
(21)
|
(25)
|
(30)
|
(34)
|
(36)
|
(39)
|
(39)
|
(38)
|
(38)
|
(35)
|
(32)
|
(30)
|
(25)
|
|
| Research & Development |
(9)
|
(10)
|
(11)
|
(12)
|
(15)
|
(18)
|
(22)
|
(25)
|
(23)
|
(22)
|
(20)
|
(18)
|
(17)
|
(15)
|
(13)
|
(11)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(11)
|
0
|
0
|
|
| Operating Income |
(16)
N/A
|
(19)
-16%
|
(23)
-22%
|
(28)
-22%
|
(35)
-24%
|
(42)
-19%
|
(49)
-16%
|
(51)
-4%
|
(46)
+8%
|
(45)
+3%
|
(39)
+14%
|
(37)
+5%
|
(35)
+5%
|
(44)
-25%
|
(35)
+20%
|
(30)
+14%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Non-Reccuring Items |
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
(1)
|
(1)
|
0
|
0
|
0
|
(11)
|
0
|
(12)
|
(13)
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Pre-Tax Income |
(18)
N/A
|
(22)
-20%
|
(27)
-24%
|
(32)
-20%
|
(39)
-22%
|
(45)
-15%
|
(50)
-13%
|
(53)
-5%
|
(48)
+8%
|
(46)
+4%
|
(40)
+14%
|
(38)
+4%
|
(48)
-25%
|
(45)
+5%
|
(48)
-7%
|
(44)
+9%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(18)
|
(22)
|
(27)
|
(32)
|
(39)
|
(45)
|
(50)
|
(53)
|
(48)
|
(46)
|
(40)
|
(38)
|
(48)
|
(45)
|
(49)
|
(44)
|
|
| Net Income (Common) |
(18)
N/A
|
(22)
-20%
|
(27)
-24%
|
(32)
-20%
|
(39)
-22%
|
(45)
-15%
|
(50)
-13%
|
(53)
-5%
|
(48)
+8%
|
(46)
+4%
|
(40)
+14%
|
(39)
+3%
|
(49)
-26%
|
(47)
+4%
|
(52)
-10%
|
(48)
+8%
|
|
| EPS (Diluted) |
-11.09
N/A
|
-13.28
-20%
|
-16.42
-24%
|
-19.7
-20%
|
-38.48
-95%
|
-27.42
+29%
|
-30.77
-12%
|
-32.21
-5%
|
-29.61
+8%
|
-28.15
+5%
|
-24.18
+14%
|
-23.37
+3%
|
-29.56
-26%
|
-28.2
+5%
|
-29.97
-6%
|
-27.03
+10%
|
|